EP3464288
[8-(Fenýlsúlfónýl)-3,8-díasabísýkló[3.2.1]okt-3-ýl](1H-1,2,3-tríasól-4-ýl)metanón
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.5.2017EP published:
23.12.2020EP application number:
17725242.6
EP translation filed:
5.3.2021Grant published:
15.3.2021EPO information:
European Patent Register
Max expiry date:
22.5.2037Expiry date:
22.5.2026Next due date:
31.5.2026
Title:
[8-(PHENYLSULFONYL)-3,8-DIAZABICYCLO[3.2.1]OCT-3-YL](1H-1,2,3-TRIAZOL-4-YL)METHANONES
Timeline
Today
23.5.2017EP application
23.12.2020EP Publication
5.3.2021Translation submitted
15.3.2021Registration published
22.5.2026Expires
Owner
Name:
Bayer Pharma AktiengesellschaftAddress:
Müllerstrasse 178, 13353 Berlin, DE
Inventor
Name:
KOPPITZ, MarcusAddress:
13467 Berlin, DE
Name:
SIEBENEICHER, HolgerAddress:
10557 Berlin, DE
Name:
STEUBER, HolgerAddress:
10115 Berlin, DE
Name:
TER LAAK, AntoniusAddress:
12159 Berlin, DE
Name:
NUBBEMEYER, ReinhardAddress:
13509 Berlin, DE
Name:
ROTTMANN, AntjeAddress:
13089 Berlin, DE
Name:
IRLBACHER, HorstAddress:
10405 Berlin, DE
Name:
BADER, BenjaminAddress:
13467 Berlin, DE
Name:
PETERS, MichaeleAddress:
10405 Berlin, DE
Name:
WAGENFELD, AndreaAddress:
12205 Berlin, DE
Name:
TEREBESI, IldikoAddress:
14195 Berlin, DE
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
16171538Date:
26.5.2016Country:
EP
Number:
16178891Date:
11.7.2016Country:
EP
Classification
Categories:
C07D 487/08, A61K 31/498, A61P 15/00, A61P 29/00, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 26.4.2021
Expires: 22.5.2022
Payer: Árnason Faktor ehf.
Number: 6
Paid: 28.4.2022
Expires: 22.5.2023
Payer: Árnason Faktor ehf.
Number: 7
Paid: 28.4.2023
Expires: 22.5.2024
Payer: Árnason Faktor ehf.
Number: 8
Paid: 23.4.2024
Expires: 22.5.2025
Payer: Árnason Faktor ehf.
Number: 9
Paid: 13.5.2025
Expires: 22.5.2026
Payer: Árnason Faktor ehf.